Skip to content

Pilot study on 3D-Ultrasound of Peripheral Nerves

Pilot study on 3D-Ultrasound of Peripheral Nerves - 3D-Ultrasound of Peripheral Nerves

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47530
Enrollment
25
Registered
2018-04-30
Start date
2018-01-12
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve Disease Polyneuropathy

Interventions

Peripheral Nerves
Polyneuropathy

Sponsors

Sint Elisabeth Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - A diagnosis of CIDP, MMN, MIDN according to the international guidelines or - A diagnosis of axonal polyneuropathy, based on findings on EMG or - A diagnosis of NF1 according to the international guidelines, or genetically confirmed diagnosis of NF1 or - Healthy control: participants without any neuropathic complaints (e.g. sensory loss, loss of strength);and - Age 18-80

Exclusion criteria

Exclusion criteria: - Being physically unable to undergo sonography

Design outcomes

Primary

MeasureTime frame
Several parameters will be evaluated in this study. - CSA measurements obtained from the images acquired with 3D ultrasound. - The quality of sonographic images of 3D ultrasound over a longer tract will be evaluated semi-quantitatively following earlier published criteria. - 3D reconstruction images (and the possibility of creating them in the three groups of participants). - Volumetric measurement values (and the possibility of obtaining them in the three groups of participants). - Inter-observer variability: the CSA measurements and volumetric measurements obtained by 2 different investigators with 3D ultrasound will be compared. Also the CSA measurements obtained with 3D and 2D ultrasound by one investigator each will be compared.

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)